A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation [1]

Thrombosis and Haemostasis

Volumn 98, Issue 6, 2007, Pages 1382-1384

  McNicol, Archibald ^a   Eyer, Erin ^a   Jackson, Elke C ^a   Israels, Sara J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN; FC RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB; IMMUNOGLOBULIN G; INTEGRIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOXANE A2; VON WILLEBRAND FACTOR;

ADULT; ARTERY THROMBOSIS; BACTERIAL STRAIN; CASE REPORT; CELL SUSPENSION; CONFORMATIONAL TRANSITION; CRYOPRECIPITATION; DISEASE PREDISPOSITION; EPISTAXIS; FEMALE; FREEZING; GENETIC POLYMORPHISM; HEMARTHROSIS; HISPANIC; HUMAN; LABORATORY TEST; LETTER; MENORRHAGIA; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; STRAIN DIFFERENCE; STREPTOCOCCUS SANGUINIS; THAWING; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ADULT; BLOOD PLATELETS; FEMALE; HUMANS; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RECEPTORS, THROMBIN; STREPTOCOCCUS SANGUIS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 36949034526     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-05-0342     Document Type: Letter

References (23)

1. Noll G. Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis 1998; 140: S3-S9.
2. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
3. Nieto FJ. Viruses and atherosclerosis: A critical review of the epidemiologic, evidence. Am Heart J 1999; 138: S453-S460.
4. Valtonen VV. Role of infections in atherosclerosis. Am Heart J 1999; 138: S431-S433.
5. Griffiths PD, Hannington G, Booth JC. Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study. Lancet 1980; 1: 1387-1389.
6. Madjid M, Naghavi M, Litovsky S, et al. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730-2736.
7. Campbell LA, Kuo CC. Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 2003; 18: 48-54.
8. Mayr M, Kiechl S, Mendall MA, et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003; 34: 610-615.
9. Armitage GC. Periodontal infections and cardiovascular disease - how strong is the association? Oral Dis 2000; 6: 335-350.
10. Haynes WG, Stanford C. Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler Thromb Vase Biol 2003; 23: 1309-1311.
11. Rajasuo A, Perkki K, Nyfors S, et al. Bacteremia following surgical dental extraction with an emphasis on anaerobic strains. J Dent Res 2004; 83: 170-174.
12. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999; 138: S534-S536.
13. Herzberg MC, Nobbs A, Tho L, et al. Oral streptococci and cardiovascular disease: searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis. J Periodontol 2005; 76: 2101-2105.
14. Herzberg MC, Brintzenhofe KL, Clawson CC. Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun 1983; 39: 1457-1469.
15. Erickson PR, Herzberg MC. Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis. J Biol Chem 1990; 265: 14080-14087.
16. Ford I, Douglas CW, Cox D, et al. The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis. Br J Haematol 1997; 97: 737-746.
17. Pampolina C, McNicol A. Streptococcus sanguis- induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcγRIIA and αIIbβ3. Thromb Haemost 2005; 93: 932-939.
18. McNicol A, Zhu R, Pesun R, et al. A role for immunoglobulin G in donor-specific Streptococcus sanguis- induced platelet aggregation. Thromb Haemost 2006; 95: 288-293.
19. Bennett E, Dormandy K. Pool's cryoprecipitate and exhausted plasma in the treatment of von Willebrand's Disease and factor XI deficiency. Lancet 1966; 2: 731-732.
20. Ford I, Douglas CW, Preston FE, et al. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Br J Haematol 1993; 84: 95-100.
21. Kerrigan SW, Douglas I, Wray A, et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002; 100: 509-516.
22. Soberay AH, Herzberg MC, Rudney JD, et al. Responses of platelets to strains of Streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost 1987; 57: 222-225.
23. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006; 4: 445-457.